1. Home
  2. Browse
  3. National Institutes of Health
  4. RFA-DA-26-034

RFA-DA-26-034National Institutes of HealthR01

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

Deadline
Award ceiling
$300,000
Awards
Not stated
Posted
Nov 20, 2024

Official announcement on the NIH Guide · opens the funder's page. Always confirm dates there.

Or read the full text and all 3 standing review criteria here, free with an account. Create free account

Summary

This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (e.g., fentanyl and xylazine)…

Related NIH announcements3

Other open R01 announcements on related subjects, with at least two weeks to go.

Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)

RFA-DA-26-055National Institutes of Health3 review criteria on fileagency framework

—

Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)

PAR-25-379National Institutes of Health3 review criteria on file

—

High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

RFA-DA-25-024National Institutes of Health3 review criteria on fileagency framework

—

The full announcement, free with an account

  • The full announcement text, not just the first two sentences
  • All 3 standing review criteria National Institutes of Health applies to this kind of proposal (its standard framework, not criteria written for this announcement)

On Plus, $39 a month

  • The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
  • Funded precedents: what similar NIH projects received, from the award records in NIH RePORTER
  • A Reviewer Scorecard of your draft against these criteria
Create free accountSign in

No card required. Browsing is free.

Subjects

More from National Institutes of Health

Open now with at least two weeks to apply, soonest deadline first.

Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)

RFA-DK-27-125National Institutes of Health

—

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

PAR-25-374National Institutes of Health3 review criteria on fileagency framework

$1M

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

PAR-25-095National Institutes of Health3 review criteria on file

$350k

BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)

RFA-DA-27-004National Institutes of Health3 review criteria on file

—

Everything open from National Institutes of Health

Related by subject

Open opportunities sharing the most subjects with this one (Substance use), with at least two weeks to apply.

NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)

PAR-24-089National Institutes of Health5 review criteria on fileagency framework

$750k

D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)

PAS-25-236National Institutes of Health3 review criteria on fileagency framework

—

OJJDP FY 2026 Mentoring for Youth Impacted by Opioids and Other Substance Use

O-OJJDP-2026-172743Office of Juvenile Justice Delinquency Prevention

$2M

Everything open tagged Substance use

Source record: https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-26-034.htmlVia the NIH Guide. Last checked against the source . Always confirm dates with the funder.